A Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare Tumours

This study is currently recruiting participants.
Verified January 2014 by NCIC Clinical Trials Group
Sponsor:
Information provided by (Responsible Party):
NCIC Clinical Trials Group
ClinicalTrials.gov Identifier:
NCT01396408
First received: July 14, 2011
Last updated: February 18, 2014
Last verified: January 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2015
  Estimated Primary Completion Date: July 2015 (Final data collection date for primary outcome measure)